One reason may be that the SARS-CoV-2 increases the risk of psychiatric disorders in patients by increasing the levels of inflammatory factors, such as interleukin-6 (IL-6) and interleukin-8 (IL-8), in the blood and cerebrospinal fluid (36). This evidence concerns the gene IL6 and psychiatric disorder.